London, United Kingdom--(Newsfile Corp. - March 18, 2026) - AgilityPortal, a leading digital workplace platform provider, has released new research analyzing workplace platform adoption trends, hybrid ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and ...

LAS VEGAS – Improving trust in data exchange depends on ensuring data provenance and understanding its importance, said Didi Davis, vice president of informatics, conformance and interoperability at ...

In the world of music investors, London-based Cutting Edge Group is an interesting anomaly. Where most PE firms in the asset class target the catalogs of iconic or well-known pop/rock bands and solo ...

Abstract: The effectiveness of dimension reduction analysis for high-dimensional process data is crucial to ensure industrial safety. Manifold learning methods can be advanced by considering both ...

Enterprises still struggle to align governance, analytics, and AI despite years of data investment — that’s because what they really need is a structural reset of the data core itself that would unify ...

Clinical research is evolving rapidly. Trials are more complex, data sources keep expanding, and regulators expect greater transparency and reproducibility. In parallel, AI is transforming how data is ...

JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Redwire Corporation (RDW), a global leader in space and defense technology solutions, today announced the sunsetting of the Edge Autonomy brand and full ...

Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced the sunsetting of the Edge Autonomy brand and full assumption of uncrewed aerial systems ...

When voters move from emotional frustration to causal reasoning, elections follow. What’s also notable is what didn’t happen. Despite intense media coverage of foreign crises – Gaza, Syria, Venezuela ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...